These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23382873)

  • 21. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
    Amin AS; Boink GJ; Atrafi F; Spanjaart AM; Asghari-Roodsari A; Molenaar RJ; Ruijter JM; Wilde AA; Tan HL
    Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic basis of Brugada syndrome: a mutation update.
    Hedley PL; Jørgensen P; Schlamowitz S; Moolman-Smook J; Kanters JK; Corfield VA; Christiansen M
    Hum Mutat; 2009 Sep; 30(9):1256-66. PubMed ID: 19606473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of
    Palladino A; Papa AA; Petillo R; Scutifero M; Morra S; Passamano L; Nigro V; Politano L
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts.
    Herbert E; Chahine M
    Can J Physiol Pharmacol; 2006; 84(8-9):795-802. PubMed ID: 17111025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.
    Giudicessi JR; Ye D; Tester DJ; Crotti L; Mugione A; Nesterenko VV; Albertson RM; Antzelevitch C; Schwartz PJ; Ackerman MJ
    Heart Rhythm; 2011 Jul; 8(7):1024-32. PubMed ID: 21349352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Brugada syndrome.
    Escárcega RO; Jiménez-Hernández M; Garcia-Carrasco M; Perez-Alva JC; Brugada J
    Acta Cardiol; 2009 Dec; 64(6):795-801. PubMed ID: 20128157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinic and genetic polymorphism of Brugada syndrome in Russian patients, caused by mutation in SCN5A gene].
    Zakliaz'minskaia EV; Shestak AG; Revishvili ASh; Pronicheva IV; Podoliak DG; Nechaenko MA; Poliakov AV; Dzemeshkevich SL
    Khirurgiia (Mosk); 2013; (2):49-53. PubMed ID: 23503384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
    Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ
    Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome.
    Peeters U; Scornik F; Riuró H; Pérez G; Komurcu-Bayrak E; Van Malderen S; Pappaert G; Tarradas A; Pagans S; Daneels D; Breckpot K; Brugada P; Bonduelle M; Brugada R; Van Dooren S
    Circ J; 2015; 79(10):2118-29. PubMed ID: 26179811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of
    Ozhathil LC; Rougier JS; Arullampalam P; Essers MC; Ross-Kaschitza D; Abriel H
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
    London B; Michalec M; Mehdi H; Zhu X; Kerchner L; Sanyal S; Viswanathan PC; Pfahnl AE; Shang LL; Madhusudanan M; Baty CJ; Lagana S; Aleong R; Gutmann R; Ackerman MJ; McNamara DM; Weiss R; Dudley SC
    Circulation; 2007 Nov; 116(20):2260-8. PubMed ID: 17967977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.
    Demion M; Thireau J; Gueffier M; Finan A; Khoueiry Z; Cassan C; Serafini N; Aimond F; Granier M; Pasquié JL; Launay P; Richard S
    PLoS One; 2014; 9(12):e115256. PubMed ID: 25531103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
    Hu D; Barajas-Martinez H; Nesterenko VV; Pfeiffer R; Guerchicoff A; Cordeiro JM; Curtis AB; Pollevick GD; Wu Y; Burashnikov E; Antzelevitch C
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):274-85. PubMed ID: 20025708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta-analysis.
    Rattanawong P; Chenbhanich J; Mekraksakit P; Vutthikraivit W; Chongsathidkiet P; Limpruttidham N; Prasitlumkum N; Chung EH
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12589. PubMed ID: 30126015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.